Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


8th World Congress on Epigenetics and Chromosome

Zurich, Switzerland

Edward H. Abraham, TMD

Oklahoma Surgical Hospital, Tulsa Oklahoma


Edward H. Abraham graduated from Harvard University with a college major in engineering, applied physics and chemistry. He
was then accepted into the first class of the Harvard - MIT graduate program in Health Sciences and Technology and subsequently
received his MD from Harvard Medical School. During his medical school training, he gained valuable research experience working
in the laboratories of Professors Judah Folkman, Claude Lechene and Nobel Laureate Konrad Bloch. During his internship, residency
and fellowship in pediatrics at Boston Children’s HospitalMedical Center, he worked directly with Professor Harry Shwachman and in
the laboratory of Professor Jan Breslow focusing on cystic fibrosis (CF). He extended his CF studies with a subsequent post-doctoral
research clinical investigator award from NIH. His work focused on membrane biochemistry in the laboratory of Professor Guido
Guidotti at Harvard University. During these investigations, he discovered and investigated functions of ATP releasing pathways using
biochemical and electrophysiological (patch-clamp) assays. He developed luciferase assays for precise measurement and imaging of
extracellular ATP clouds. Dr. Abraham then completed a radiation oncology residency at Massachusetts General Hospital, Boston and
subsequent Senior Investigator position with Dr. Paul Okunieff at the National Cancer Institute (NCI) where the role of extracellular
ATP in cancer treatment was investigated. He subsequently assumed directorship of the Radiation Oncology Translational Research
laboratory at Dartmouth Medical School in Hanover, NH. At Dartmouth he ran clinical trials testing the effects of ATP intravenous
infusions on patients with stage IV cancers


Abstract : Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV